PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

NCT04165174 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HCC

Interventions

DRUG: Terepril monoclonal antibody; Apatinib
RADIATION: SBRT

Sponsor

Huazhong University of Science and Technology